https://invesbrain.com/merck-kgaa-bets-big-on-dna-damage-upstart-pushing-30m-upfront-and-hefty-incentives-for-a-lynparza-pioneer/
Merck KGaA bets big on DNA damage upstart, pushing $30M upfront and hefty incentives for a Lynparza pioneer